Estrogen release from metallic stent surface for the prevention of restenosis

Journal of Controlled Release

Volumn 92, Issue 1-2, 2003, Pages 83-91

  Joung, Yoon Ki ^a   Kim, Hyun Il ^b   Kim, Sung Soo ^b   Chung, Kwang Hoe ^c   Jang, Yang Soo ^c   Park, Ki Dong ^a  

^a Ajou University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Estrogen immobilization; Estrogen releasing stent; In vitro release; Metallic stent; Restenosis

Indexed keywords

CHEMICAL ACTIVATION; CHEMICAL BONDS; HORMONES; SURFACE PROPERTIES; X RAY PHOTOELECTRON SPECTROSCOPY;

RESTENOSIS;

DRUG PRODUCTS;

ESTRADIOL; SILANE; STAINLESS STEEL;

ARTICLE; CORONARY STENT; COVALENT BOND; DRUG RETENTION; ESTROGEN RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; POLYMERIZATION; PRIORITY JOURNAL; PROPHYLAXIS; RESTENOSIS; SUSTAINED DRUG RELEASE; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY PHOTOELECTRON SPECTROSCOPY;

EID: 0141853289     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00305-5     Document Type: Article

References (29)

1. Forrester J.S., Fishbein M., Helfant R., Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J. Am. Coll. Cardiol. 17:1991;752-757.
2. Luscher T.F., Turina M., Braunwald E. Coronary Artery Graft Disease: Mechanisms and Prevention. 1994;Springer, Heidelberg.
3. Nobuyoshi M., Kimura T., Ohishi H. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observation in 20 patients. J. Am. Coll. Cardiol. 17:1991;433-439.
4. Landzberg B.R., Frishman W.H., Lerrick K. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Prog. Cardiovasc. Dis. 39:1997;361-398.
5. Lefkovits J., Tolol E.J. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. Prog. Cardiovasc. Dis. 40:1997;141-158.
6. Lincoff A.M., Topol E.J., Ellis S.G. Local drug delivery for the prevention of restenosis. Fact, fancy, and future. Circulation. 90:1994;2070-2084.
7. Azrin M.A., Mitchel J.F., Bow L.M., et al. Effect of local delivery of heparin on platelet deposition during in-vivo balloon angioplasty using hydrogel-coated balloons. Circulation. 88:(Suppl. I):1993;I-310. abstract.
8. Mitchel J.F., Fram D.B., Palme D.F., et al. Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system: in vitro, in vivo and clinical studies. Circulation. 91:1995;785-793.
9. Fernandez-Ortiz A., Meyer B.J., Mailhac A., et al. Intravascular local delivery: an iontophoretic approach. Circulation. 88:(Suppl. I):1993;I-308. abstract.
10. Langer R. New methods of drug delivery. Science. 249:1990;1527-1533.
11. Nakayama Y., Nishi S., Ishibashi-Ueda H., Matsuda T. Surface microarchitectural design in biomedical applications: in vivo analysis of tissue ingrowth in excimer laser-directed micropored scaffold for cardiovascular tissue engineering. J. Biomed. Mater. Res. 51:2000;520-528.
12. Matsuda T. Device-directed therapeutic drug delivery systems. J. Controlled Release. 78:2002;125-131.
13. Belchetz P.E. Hormonal treatment of postmenopausal women. N. Engl. J. Med. 330:1994;1062-1071.
14. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H. Menopause and the risk of coronary heart disease in women. N. Engl. J. Med. 316:1987;1105-1110.
15. NIH. Chartbook on Cardiovascular, Lung and Blood Diseases. May, 1992;US Department of Health and Human Services, Washington, DC.
16. Stallone J.N. Role of endothelium in sexual dimorphism in vasopressin-induced contraction of rat aorta. Am. J. Physiol. 265:1993;H2073-H2080.
17. Collins P., Rosano G.M.C., Sarrel P.M., et al. 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92:1995;24-30.
18. Farhat M., Lavigne M., Ramwell P. The vascular protective effects of estrogen. FASEB J. 10:1996;615-624.
19. Sullivan T. Jr., Karas R., Aronovitz M., et al. Estrogen inhibits the response to injury in a mouse carotid artery model. J. Clin. Invest. 96:1995;2482-2488.
20. Chen S., Li H., Durand J., Oparil S., Chen Y. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 93:1996;577-584.
21. d'Agostino R. Plasma Deposition, Treatment and Etching of Polymers. 1990;Academic Press, London.
22. Hollahan J.R., Wydeven T. Science. 179:1972;500.
23. Biederman H., Slavinska D. Plasma polymer films and their future prospects. Surf. Coat. Technol. 125:2000;371-376.
24. Shi F. Recent advances in polymer thin films prepared by plasma polymerization: synthesis, structural characterization, properties and applications. Surf. Coat. Technol. 82:1996;1-15.
25. Shirtcliffe N., Thiemann P., Stratmann M., Grundmeier G. Chemical structure and morphology of thin, organo-silicon plasma-polymer films as a function of process parameters. Surf. Coat. Technol. 142:(144):2001;1121-1128.
26. Alexander M.R., Payan S., Duc T.M. Interfacial interactions of plasma-polymerized acrylic acid and an oxidized aluminium surface investigated using XPS, FTIR and poly(acrylic acid) as a model compound. Surf. Interface Anal. 26:1998;961-973.
27. Russell J., Malcolm R., Campbell K., Woolifson A. High-performance liquid chromatographic determination of 17β-estradiol and 17β-estradiol-3-acetate solubilities and diffusion coefficients in silicone elastomeric intravasinal rings. J. Chromatogr. B. 744:2000;157-163.
28. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absense of endothelium. Lab. Invest. 49:1983;327-333.
29. Clowes A.W., Reidy M.A., Clowes M.M. Mechanism of stenosis after arterial injury. Lab. Invest. 49:1983;208-215.